TY - JOUR
T1 - Cervical metastasis from an unknown primary
AU - Fried, Marvin P.
AU - Diehl, William H.
AU - Brownson, Richmond Jay
AU - Sessions, Donald G.
AU - Ogura, Joseph H.
N1 - Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1975/3
Y1 - 1975/3
N2 - Forty-nine patients with cervical metastases from unknown primaries were treated during an 11-year period. Thirty-one (63%) of these patients were treated for cure rather than palliation. The three-year survival rate of these patients treated for cure was 39%. Although the treatment of these patients varied, a systematic mode of therapy has evolved: patients with histopathologic diagnosis of epidermoid carcinoma, or undifferentiated malignant tumor, metastatic to the neck from an unknown primary, are treated with full course radiation therapy (6000–7000 rads at 1000 rads per week). This is delivered to the nasopharynx, pyriform fossae, base of tongue, and the neck, and is followed by radical neck dissection in those patients in whom the neck nodes remain palpable. Six of the last 11 consecutive patients treated in this manner are long-term survivors. This paper describes the evaluation of patients with cervical metastases from unknown primaries as well as their therapy.
AB - Forty-nine patients with cervical metastases from unknown primaries were treated during an 11-year period. Thirty-one (63%) of these patients were treated for cure rather than palliation. The three-year survival rate of these patients treated for cure was 39%. Although the treatment of these patients varied, a systematic mode of therapy has evolved: patients with histopathologic diagnosis of epidermoid carcinoma, or undifferentiated malignant tumor, metastatic to the neck from an unknown primary, are treated with full course radiation therapy (6000–7000 rads at 1000 rads per week). This is delivered to the nasopharynx, pyriform fossae, base of tongue, and the neck, and is followed by radical neck dissection in those patients in whom the neck nodes remain palpable. Six of the last 11 consecutive patients treated in this manner are long-term survivors. This paper describes the evaluation of patients with cervical metastases from unknown primaries as well as their therapy.
UR - http://www.scopus.com/inward/record.url?scp=0016690968&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016690968&partnerID=8YFLogxK
U2 - 10.1177/000348947508400202
DO - 10.1177/000348947508400202
M3 - Article
C2 - 1124902
AN - SCOPUS:0016690968
SN - 0003-4894
VL - 84
SP - 152
EP - 157
JO - Annals of Otology, Rhinology & Laryngology
JF - Annals of Otology, Rhinology & Laryngology
IS - 2
ER -